General Information

Government Type

State Agency

Entity

Department of Health and Human Services (DHHS)

Public Body

Pharmacy and Therapeutics Committee

Notice Information

Add Notice to Calendar

Notice Title

State Medicaid P&T Committee Meeting

Notice Tags

Medicaid, Pharmacies

Notice Type(s)

Meeting

Event Start Date & Time

September 21, 2017 07:15 AM

Event End Date & Time

September 21, 2017 08:45 AM

Event Deadline Date & Time

09/21/17 01:00 AM

Description/Agenda

AGENDA Utah Department of Health Pharmacy and Therapeutics Committee Thursday, September 21, 2017 7:15 a.m. to 8:45 a.m. Cannon Health Building Room 128 Persons who wish to address the P&T Committee may contact Bryan S. Larson at (bslarson@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Clinton Sheffield, MD, Chair a) Announce Quorum 2) Welcome and Introductions - Clinton Sheffield, MD, Chair a) Review and Approval of Minutes b) Housekeeping 3) DUR Board Update - Robyn Seely, PharmD 4) September Review a) Opioid Dependence Treatments - Elena Martinez Alonso i) Physician Administered Buprenorphine (implant), Naltrexone (long acting injectable) (1) REMS Discussions (a) Vivitrol REMS program - Tim Birner (b) Probuphine REMS program - Jessica Hartung, PharmD ii) Oral Buprenorphine (sublingual), Buprenorphine/Naloxone, Naltrexone (1) REMS Discussion (a) Suboxone REMS program - Christy Skibicki, MD b) Public Comment i) Alkernes - Kenneth Berry, PharmD c) Other States Report - Bryan S. Larson, PharmD d) Committee Discussion/Questions e) Committee Action 5) Next Meeting October 19, 2017, Long-Acting Beta-2 Agonist & Glucocorticoid Combinations 6) Adjourned - Clinton Sheffield, MD, Chair The foundation documents used for most reviews are prepared by the University of Utah, College of Pharmacy, and are posted on the P&T Committee website after the meeting. Manufacturers wishing to submit any additional materials they would like reviewed as part of the process to: Dr. Joanne LaFleur College of Pharmacy 30 South 2000 East SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible), unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Tentative 2017 Pharmacy & Therapeutics Committee Schedule Month Topic Agents 19 Oct 2017* Long-Acting Beta-2 Agonist & Glucocorticoid Combinations Budesonide/Formoterol, Fluticasone/Salmeterol, Fluticasone/Vilanterol, Mometasone/ Formoterol 16 Nov 2017* DPP-4 Inhibitors Alogliptin, Linagliptin, Saxagliptin, Sitagliptan 21 Dec 2017* DPP-4 Inhibitor Combinations Alogliptin/Metformin, Alogliptin/Pioglitazone, Linagliptin/Metformin, Linagliptin/ Empagliflozin, Saxagliptin/Metformin, 18 Jan 2018* Antiplatelet Agents (1) TBD 15 Feb 2018* Antiplatelet Agents (2) TBD 16 Mar 2018* Nasal Corticosteroids Beclomethasone, Budesonide, Ciclesonide, Flunisolide, Fluticasone Furoate, Fluticasone Propionate, Mometasone *Please note: all topics are tentative and subject to change.

Notice of Special Accommodations (ADA)

In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Bryan Larson at 801-538-6149.

Notice of Electronic or Telephone Participation

N/A

Meeting Information

Meeting Location

288 North 1460 West
Cannon Health Building - Room 128
Salt Lake City, 84116
Show in Apple Maps Show in Google Maps

Contact Name

Ngan Huynh

Contact Email

nganhuynh@utah.gov

Contact Phone

801-538-6155

Notice Posting Details

Notice Posted On

September 05, 2017 04:08 PM

Notice Last Edited On

September 12, 2017 10:38 AM

Deadline Date

September 21, 2017 01:00 AM

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.